InvestSMART

Oncosil Medical Limited (ASX:OSL)

ALERT: Price-sensitive ASX Announcement for OSL
Current share price for OSL : $1.100 0.665 (152.87%)+
Announcement
Release
4 Jun 2026 9:09AM
Price at Release
$0.435
Full Release
download
Summary
OncoSil Medical Ltd (OSL) has requested a trading halt on the ASX pending the release of an important announcement. The halt is related to the material results of the TRIPP-FFX clinical trial and regulatory correspondence with the U.S. FDA. The halt is effective immediately and will remain in place until the earlier of the announcement release or the resumption of normal trading on Tuesday, 9 June 2026. This request has been duly authorized by the company's Board of Directors.
Key Points
  • OncoSil Medical Ltd has requested a trading halt on the ASX.
  • The trading halt is pending an announcement by OncoSil Medical Ltd.
  • The halt is related to the results of the TRIPP-FFX clinical trial and correspondence with the U.S. FDA.
  • The trading halt will remain until either the announcement is made or trading resumes on 9 June 2026.
  • The request for the trading halt was authorized by OncoSil Medical's Board of Directors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.